Hi, I am not a patient, however, my dad was diagnosed with M M in March. He is in his final week of his quad treatment, and for the most part has done very well. However, he has been experiencing migraines for the last two weeks. They are progressively getting more frequent and are debilitating. His local oncologist prescribed him Sumatriptan which helps for a little while, but they come back. He also scheduled him to have an MRI this week. Has anyone experienced this with the quad treatment? Does anybody have any recommendations for something else that can be prescribed to him? He does not meet with his specialist at city of Hope until July 8 and his local oncologist is on vacation for a week. His primary care doctor will not prescribe him anything because of his treatment. Thank you in advance!

Your Feed
Filter by
See content from
Playlist: Autologous Stem Cell Transplant (ASCT)
How long will I be immunocompromised? How can I prevent infection after transplant?
Video details & playlist
Playlist: Autologous Stem Cell Transplant (ASCT)
How long is the average stay for an ASCT? How will the doctor know when I am able to return home or no longer come for daily clinic visits?
Video details & playlist
Playlist: EHA 2025
Belantamab Mafodotin Updates & How to Manage Eye Side Effects | Evangelos Terpos, MD, PhD | #EHA2025
Video details & playlist
Playlist: EHA 2025
New Insights into High-Risk Amyloidosis Staging | Jahanzaib Khwaja, MD, FRCPath | #EHA2025
Video details & playlist
Playlist: EHA 2025
Revolutionizing Myeloma Care: AI Matches Patients to Trials | Jorge Hurtado Martinez, MD | EHA 2025
Video details & playlist
Playlist: EHA 2025
Belantamab Mafodotin in the Real World: Promising Myeloma Data | Fredrik Schjesvold, MD, PhD | #EHA2025
Video details & playlist
Playlist: EHA 2025
CONCEPT Trial | Isa-KRd : New Hope for High-Risk Myeloma Patients | Lisa Leypoldt, MD | #EHA2025
Video details & playlist
Playlist: EHA 2025
ADVANCE Trial | Dara‑KRd in NDMM yields ~ 60% MRD‑Negativity| Ola Landgren, MD, PhD- #EHA25 #myeloma
Video details & playlist
Playlist: EHA 2025
IRAKLIA Trial: On-Body Subcutaneous Isatuximab Delivery in Myeloma | Muhamed Baljevic, MD | #EHA2025
Video details & playlist
Playlist: EHA 2025
HDP‑101: Promising Anti‑BCMA ADC with Novel Payload for Myeloma | Shambavi Richard, MD | EHA 2025
Video details & playlist




